BEST4 Surveillance Trial
A prospective cohort trial to assess whether the capsule sponge test, together with a biomarker panel (cytological atypia, p53 immunochemistry, age, gender, length of Barrett's Oesophagus segment) can be used to monitor patients with non-dysplastic Barrett’s Oesophagus (NDBO). Participants receive a capsule sponge test in addition to standard of care endoscopies as part of the 3-year trial. Participants are risk stratified at baseline (clinical risk factors and endoscopy) into low, moderate, or high-risk groups which will then inform the timing of follow-up assessments.
Contact Information
- Email:
- id213@medschlh.cam.ac.uk
- Address:
-
Department of Oncology
The Clifford Allbutt Buildng
Cambridge Biomedical Campus
Hills Road
Cambridge
Cambridgeshire
CB2 0AH
England
Last Updated: 06/13/2025
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025 | N/A | N/A | N/A | N/A | N/A | N/A |